MLTX Form 144 lists proposed resale of 150,000 shares

Accepted by SEC EDGAR 04/09/2026 - 04:01 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MLTX notice reports proposed sales of Common stock under Form 144 by a broker-dealer entry for UBS Financial Services, Inc. The excerpt lists proposed transactions including 150,000 shares on 04/05/2023 (exchange of share) and a 10,870-share purchase on 10/08/2025. A securities count of 71,727,875 is shown with date 04/09/2026.

Insights

Securities Compliance Attorney

Routine Form 144 disclosure listing proposed resale transactions and broker-dealer details.

Form 144 is used to notify of intended sales under resale limitations; the excerpt shows specific proposed amounts and dates such as 150,000 shares on 04/05/2023 and 10,870 shares on 10/08/2025. The presence of UBS Financial Services, Inc. suggests broker handling.

Timing and execution details are limited in the excerpt; subsequent filings or trade reports would confirm completion. Review full Form 144 and related brokerage confirmations to verify whether these proposed sales were executed.

Key Figures

Proposed resale: 150,000 shares Purchase listed: 10,870 shares Securities count: 71,727,875 +1 more

4 metrics

Proposed resale 150,000 shares 04/05/2023, listed under Securities To Be Sold

Purchase listed 10,870 shares 10/08/2025, listed under Securities To Be Sold (Purchase)

Securities count 71,727,875 Displayed in securities information with date 04/09/2026

Value listed 2,969,660.20 Numeric value shown in securities information block

Key Terms

Form 144, Exchange of share, Issuer

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exchange of share market

"Securities To Be Sold | 04/05/2023 | Exchange of share"

Issuer regulatory

"Securities To Be Sold | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MLTX Form 144 report?

Form 144 reports proposed resale transactions of MLTX common stock by a holder. The excerpt lists proposed amounts and dates, including 150,000 shares on 04/05/2023 and 10,870 shares on 10/08/2025, plus broker-dealer information for processing.

Who is the broker handling the MLTX transactions?

The broker-dealer listed is UBS Financial Services, Inc. at a Weehawken, NJ address. That entry appears alongside the proposed sales and is the firm shown for execution or representation in the excerpt.

Does the excerpt show shares outstanding for MLTX?

The excerpt includes a figure of 71,727,875 with the date 04/09/2026. This number appears in the securities information block and may represent a share count shown in the filing excerpt.

Do the listed transactions mean shares were sold?

No. Form 144 entries notify intended resales; the excerpt lists proposed transactions such as 150,000 shares but does not confirm execution. Trade confirmations or subsequent filings would verify whether sales occurred.

What regulatory purpose does Form 144 serve for MLTX?

Form 144 provides notice of intent to sell restricted or control securities under resale rules. The excerpt shows amounts and broker details needed to comply with resale reporting obligations prior to or concurrent with sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001920545
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MoonLake Immunotherapeutics
SEC File Number	001-39630
Address of Issuer	DORFSTRASSE 29 ZUG SWITZERLAND 6300
Phone	41 41 510 8022
Name of Person for Whose Account the Securities are To Be Sold	Bodenstedt Matthias
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	CFO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	160870	2969660.20	71727875	04/09/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/05/2023	Exchange of share	Issuer			150000	04/05/2023	Cash
Common	10/08/2025	Purchase	Issuer			10870	10/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Matthias Bodenstedt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)